Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENTS (Tables)

v3.22.2.2
FAIR VALUE MEASUREMENTS (Tables)
 6 Months Ended
Jun. 30, 2022
Fair Value Disclosures [Abstract]  
SCHEDULE OF FINANCIAL INSTRUMENT MEASURED ON RECURRING BASIS

 

    As of June 30, 2022     Fair Value Measurements  
    Carrying     Fair     As of June 30, 2022  
    Amount     Value     Level 1     Level 2     Level 3  
                (unaudited)              
Liabilities:                              
Contingent consideration:                                        
Asuragen (1)   $ 1,281     $ 1,281     $ -     $ -     $ 1,281  
Other accrued expenses:                                        
Warrant liability (2)     3       3       -       -       3  
Note payable:                                        
BroadOak loan     7,782       7,782       -       -       7,782  
BroadOak convertible note     2,000       2,000       -       -       2,000  
    $ 11,066     $ 11,066     $ -     $ -     $ 11,066  

 

(1)(2) See Note 9, Accrued Expenses and Long-Term Liabilities
(1)
(2)

 

    As of December 31, 2021     Fair Value Measurements  
    Carrying     Fair     As of December 31, 2021  
    Amount     Value     Level 1     Level 2     Level 3  
Liabilities:                                        
Contingent consideration:                                        
Asuragen (1)   $ 1,871     $ 1,871     $ -     $ -     $ 1,871  
Other accrued expenses:                                        
Warrant liability (2)     71       71       -       -       71  
Note payable:                                        
BroadOak loan     7,942       7,942       -       -       7,942  
    $ 9,884     $ 9,884     $ -     $ -     $ 9,884  

 

 

(1)(2) See Note 9, Accrued Expenses and Long-Term Liabilities
(2)
SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION

A roll forward of the carrying value of the Contingent Consideration Liability, 2017 Underwriters’ Warrants and BroadOak Loans to June 30, 2022 is as follows:

  

                            Adjustment        
    December 31, 2021     Issued     Earned    

Accretion/

Interest Accrued

     to Fair Value/ Mark to Market     June 30, 2022  
    (unaudited)  
Asuragen   $ 1,871       -      $ (364 )   $ 85     $ (311 )   $ 1,281  
                                                 
Underwriters Warrants     71               -       -       (68 )     3  
                                                 
BroadOak Loan     7,942               -       -       (160 )     7,782  
                                                 
BroadOak Convertible Note     -       2,000       -       -       -       2,000  
    $ 9,884     $ 2,000     $ (364 )   $ 85     $ (539 )   $ 11,066